Welcome to the e-CCO Library!

P667: Unmet needs in the management of Inflammatory Bowel Diseases in Egypt
Year: 2022
Source: ECCO'22
Authors: KhorshidFASGE, M.(1);Abdel-Gawad, M.(2);AbdAllah, M.(3);Tag-Adeen, M.(4);Afify, S.(5);El Deeb, R.(6);Elshaarawy, O.(7);Elbasiony, M.(8);Bassuny, A.N.(9);El-Raey, F.(10);Fathy, H.(11);ElShabacy, O.(12);Cordie, A.(13);Abdelmoaty, A.(14);Elbahr, O.(7);Ali-Eldin, Z.(15);Alboraie, M.(16);
Created: Friday, 11 February 2022, 3:56 PM
P667: USTEkinumAb Double intravenous loading induction therapY at week 0,4 in patients with Crohn's Disease– results from STEADY study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Chin, A.(1)*;Jeffrey, A.(1);Teh, W.L.(1);Menon, S.(1);So, K.(1);Venugopal, K.(1);Picardo, S.(1);
Created: Friday, 14 July 2023, 11:12 AM
P668 Real-life comparison of different anti-TNF biologic therapies for ulcerative colitis treatment: A retrospective cohort study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

B. Barberio, F. Zingone, R. D’Incà, C. Marinelli, M.C. Maccarone, A. Gubbiotti, L. Cingolani, G. Lorenzon, M. Ghisa, E.V. Savarino

Created: Thursday, 30 January 2020, 10:12 AM
P668: Differential efficacy of biologic agents for Inflammatory Bowel Disease Unclassified and comparison with Ulcerative Colitis: a propensity score analysis of 4054 patients from the UK IBD BioResource
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kapizioni, C.(1)*;Desoki, R.(1,2);Balendran, K.(1);Lam, D.(1);Shawky, R.(3);Pele, L.(3);Parkes, M.(1);Raine, T.(1);
Created: Friday, 14 July 2023, 11:12 AM
P668: Does biotin deficiency play a role in the pathogenesis of Inflammatory Bowel Disease? Preliminary results of a cross-sectional study
Year: 2021
Source: ECCO'21 Virtual
Authors: Erbach, J.(1);Arnold, A.(2);Bonn, F.(2);Stein, J.M.(1,3,4);Schröder, O.(1,3);Aksan, A.(1,5);
Created: Wednesday, 2 June 2021, 4:12 PM
P668: Measured and modelled data suggest that oral administration of V565, a novel domain antibody to TNF-alpha, could be beneficial in the treatment of IBD
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Nurbhai1*, M. West1, T. MacDonald2, G. Parkes3, P. Irving4, A. Vossenkaemper2, S. Crowe1

Created: Thursday, 21 February 2019, 9:14 AM
P668: Post-marketing experience of vedolizumab in inflammatory bowel disease: analysis of pneumonia and other respiratory tract infections
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Bhayat F.1, Blake A.*2, Travis S.3

Created: Wednesday, 20 February 2019, 10:36 AM
P668: Real world use and adverse events of SARs-CoV-2 vaccination in Greek patients with Inflammatory Bowel Disease
Year: 2022
Source: ECCO'22
Authors: Orfanoudaki, E.(1);Zacharopoulou, E.(2);Kitsou, V.(3);Karmiris, K.(4);Theodoropoulou, A.(4);Mantzaris , G.J.(5);Tzouvala, M.(2);Michopoulos , S.(6);Zampeli, E.(6);Michalopoulos, G.(7);Karatzas, P.(8);Viazis, N.(5);Liatsos, C.(9);Bamias, G.(10);Koutroubakis, I.E.(1);
Created: Friday, 11 February 2022, 3:56 PM
P668: Ustekinumab induction effectiveness in Crohn’s disease in a real-life cohort
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Rullan1, A. Elosua*1, C. Saldaña1, E. Amorena1, M. Vicuña1, S. Rubio1, Ó. Nantes1, C. Rodríguez1

Created: Friday, 22 February 2019, 9:41 AM
P669 Adherence to self-administered biologic therapies in inflammatory bowel disease: Experience in a tertiary hospital
Year: 2020
Source:

ECCO'20 Vienna

Authors:

L. Ramos Lopez1, J. Ramos Rodríguez2, R. De La Barreda1, F. Guitierrez2, G.J. Nazco Casariego2, I. Alonso Abreu1, M. Carrillo Palau1, E. Quintero1

Created: Thursday, 30 January 2020, 10:12 AM
P669: Adalimumab long-term effectiveness in adalimumab-naïve patients with Crohn's disease: final data from PYRAMID registry
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Loftus Jr. E.*1, D'Haens G.2, Reinisch W.3, Satsangi J.4, Panaccione R.5, Berg S.6, Alperovich G.7, Bereswill M.8, Kalabic J.8, Skup M.9, Petersson J.9, Robinson A.M.9

Created: Wednesday, 20 February 2019, 10:36 AM
P669: Effect of vedolizumab therapy on whole blood transcriptional profiles in patients with Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Haglund, S.(1,2,3);Söderman, J.(1,3);Almer, S.(2,4);
Created: Wednesday, 2 June 2021, 4:12 PM
P669: Human β-defensin 2 suppresses TNF-α secretion in human and mouse dendritic cells mediated by chemokine receptor-2
Year: 2018
Source: ECCO '18 Vienna
Authors:

N.S. Armbruster1, K. Sidelmann Brinch2, B. Andersen2, E.F. Stange1, N. Malek1, P. Nordkild3, J. Wehkamp1*

Created: Thursday, 21 February 2019, 9:14 AM
P669: Improving Crohn's disease stricture dilation outcome: Effect of repeated dilation, needle knife stricturotomy, and ongoing active inflammation
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Schulberg, J.D.(1,2)*;Hamilton, A.L.(1,2);Wright, E.K.(1,2);Holt, B.(1,2);Sutherland, T.(2,3);Ross, A.L.(1);Vogrin, S.(2);Kamm, M.A.(1,2);
Created: Friday, 14 July 2023, 11:12 AM
P669: Transmural healing is associated with higher infliximab trough levels in Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Albshesh1, B. Unger1,2, S. Ben Horin2, R. Eliakim2, U. Kopylov2, D. Carter*2

Created: Friday, 22 February 2019, 9:41 AM
P669: Validation of prior infliximab exposure and total colectomy outcome in patients with ulcerative colitis in Sweden
Year: 2022
Source: ECCO'22
Authors: Huang, Z.(1);Hill, D.(1);Bengtsson, C.(2);Wang, M.(2);Hakkarainen, K.M.(3);Hellström, P.M.(4);
Created: Friday, 11 February 2022, 3:56 PM
P670 Usefulness of monitoring the concentration of azathioprine metabolites in the children with inflammatory bowel disease and autoimmune hepatitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

K. Bąk-Drabik1, J. Duda-Wrońska2, D. Dąbrowska-Piechota2, P. Adamczyk3

Created: Thursday, 30 January 2020, 10:12 AM
P670: Comparative efficacy on steroid-free remission of pharmacological therapies for moderate-to-severe ulcerative colitis: A systematic review and network meta-analysis
Year: 2018
Source: ECCO '18 Vienna
Authors:

P. Paschos1,2, A. Katsoula3, O. Giouleme3*, A. Tsapas1,4

Created: Thursday, 21 February 2019, 9:14 AM
P670: Evaluating the management of Vitamin D in Crohn's disease patients in a secondary care population
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ahmed R., O'Connell G., Love M., Davis J., Cooney R., Pathmakanthan S., Iqbal T., Bhala N.

Created: Wednesday, 20 February 2019, 10:36 AM
P670: Familial Inflammatory Bowel Disease is associated with a more adverse disease compared to sporadic cases
Year: 2022
Source: ECCO'22
Authors: Boaz, E.(1);Ariella, B.G.S.(2);Menachem, S.(2);Eran, G.(2);Petachia, R.(1);Shlomo, Y.(1);Koslowsky, B.(2);
Created: Friday, 11 February 2022, 3:56 PM